User profiles for Valeria De Giorgi
Valeria De GiorgiNational Institutes of Health Verified email at mail.nih.gov Cited by 1366 |
[HTML][HTML] An immunologic portrait of cancer
ML Ascierto, VD Giorgi, Q Liu, D Bedognetti… - Journal of translational …, 2011 - Springer
The advent of high-throughput technology challenges the traditional histopathological
classification of cancer, and proposes new taxonomies derived from global transcriptional patterns…
classification of cancer, and proposes new taxonomies derived from global transcriptional patterns…
[HTML][HTML] Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
In humans, the role and relationship between molecular pathways that lead to tissue destruction
during acute allograft rejection are not fully understood. Based on studies conducted in …
during acute allograft rejection are not fully understood. Based on studies conducted in …
[HTML][HTML] Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
M Myint, F Oppedisano, V De Giorgi, BM Kim… - Journal of Translational …, 2023 - Springer
Liver steatosis, inflammation, and variable degrees of fibrosis are the pathological
manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most …
manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most …
[HTML][HTML] CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
Background: Adoptive therapy with tumour-infiltrating lymphocytes (TILs) induces durable
complete responses (CR) in∼ 20% of patients with metastatic melanoma. The recruitment of T …
complete responses (CR) in∼ 20% of patients with metastatic melanoma. The recruitment of T …
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
…, A Worschech, V De Giorgi… - Proceedings of the …, 2012 - National Acad Sciences
Because oncogene MET and EGF receptor (EGFR) inhibitors are in clinical development
against several types of cancer, including glioblastoma, it is important to identify predictive …
against several types of cancer, including glioblastoma, it is important to identify predictive …
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection
Background Characterizing the kinetics of the antibody response to severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) is of critical importance to developing strategies …
syndrome coronavirus 2 (SARS‐CoV‐2) is of critical importance to developing strategies …
Pooled saliva specimens for SARS-CoV-2 testing
B Barat, S Das, V De Giorgi… - Journal of clinical …, 2021 - Am Soc Microbiol
We evaluated saliva (SAL) specimens for SARS-CoV-2 reverse transcriptase PCR (RT-PCR)
testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (…
testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (…
Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C
K Matsuura, V De Giorgi, C Schechterly, RY Wang… - Hepatology, 2016 - journals.lww.com
The goal of this study was to determine whether an association exists between circulating
microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether …
microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether …
[HTML][HTML] mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
…, D Esposito, Z Kang, J Lu, AT Remaley, V De Giorgi… - Scientific Reports, 2022 - nature.com
Several variants of SARS-CoV-2 have emerged. Those with mutations in the angiotensin-converting
enzyme (ACE2) receptor binding domain (RBD) are associated with increased …
enzyme (ACE2) receptor binding domain (RBD) are associated with increased …
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy
…, W Hobo, Y Ji, H Fredrix, V De Giorgi… - …, 2018 - Taylor & Francis
Adoptive T cell therapy has shown clinical potential for patients with cancer, though effective
treatment is dependent on longevity and potency of the exploited tumor-reactive T cells. …
treatment is dependent on longevity and potency of the exploited tumor-reactive T cells. …